the cancer statistics provided by American Cancer Soci- ety
in 2012, the 5-year survival rate of NHL has im- proved from 47%
in 1970s to 70%
in recent years, and rituximab has been central to this improved prognosis. [2]. However, it is important to realize that after treat- m[r]